Literature DB >> 18599537

Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation.

Brian W Jarecki1, Patrick L Sheets, James O Jackson, Theodore R Cummins.   

Abstract

Single-point missense mutations in the peripheral neuronal voltage-gated sodium channel Nav1.7 are implicated in the painful inherited neuropathy paroxysmal extreme pain disorder (PEPD). The Nav1.7 PEPD mutations are located in regions of the channel suggested to play important roles in fast inactivation. PEPD mutations in the putative inactivation gate have been reported to significantly impair fast inactivation, resulting in pronounced persistent currents. However, PEPD mutations in the S4-S5 linker of domain 3 (D3/S4-S5) had not been characterized and the roles of specific residues in this linker in channel gating are unclear. We functionally characterized two of the D3/S4-S5 PEPD mutations (V1298F and V1299F) and compared their effects on gating to an adjacent non-PEPD mutation (V1300F) and the I1461T PEPD mutation, located in the putative inactivation gate. The primary effect of the V1298F and V1299F mutations is to shift the voltage dependence of fast inactivation by approximately 20 mV in the depolarizing direction. We observed a similar effect with the PEPD mutation I1461T. Interestingly, while all three PEPD mutations increased persistent currents, the relative amplitudes (approximately 6% of peak) were much smaller than previously reported for the I1461T mutation. In contrast, the main effect of the V1300F mutation was a depolarizing shift in the voltage dependence of activation. These data demonstrate that (1) mutations within D3/S4-S5 affect inactivation of Nav1.7 in a residue-specific manner and (2) disruption of the fast-inactivated state by PEPD mutations can be more moderate than previously indicated, which has important implications for the pathophysiology of PEPD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599537      PMCID: PMC2652197          DOI: 10.1113/jphysiol.2008.154906

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  62 in total

Review 1.  From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.

Authors:  W A Catterall
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

Review 2.  Slow inactivation in voltage-gated sodium channels: molecular substrates and contributions to channelopathies.

Authors:  Y Y Vilin; P C Ruben
Journal:  Cell Biochem Biophys       Date:  2001       Impact factor: 2.194

3.  Paroxysmal extreme pain disorder (previously familial rectal pain syndrome).

Authors:  C R Fertleman; C D Ferrie; J Aicardi; N A F Bednarek; O Eeg-Olofsson; F V Elmslie; D A Griesemer; F Goutières; M Kirkpatrick; I N O Malmros; M Pollitzer; M Rossiter; E Roulet-Perez; R Schubert; V V Smith; H Testard; V Wong; J B P Stephenson
Journal:  Neurology       Date:  2007-08-07       Impact factor: 9.910

4.  Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons.

Authors:  M Renganathan; T R Cummins; S G Waxman
Journal:  J Neurophysiol       Date:  2001-08       Impact factor: 2.714

5.  A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.

Authors:  Patrick L Sheets; James O Jackson; Stephen G Waxman; Sulayman D Dib-Hajj; Theodore R Cummins
Journal:  J Physiol       Date:  2007-04-12       Impact factor: 5.182

6.  Persistent TTX-resistant Na+ current affects resting potential and response to depolarization in simulated spinal sensory neurons.

Authors:  R I Herzog; T R Cummins; S G Waxman
Journal:  J Neurophysiol       Date:  2001-09       Impact factor: 2.714

7.  Cloning, distribution and functional analysis of the type III sodium channel from human brain.

Authors:  Y H Chen; T J Dale; M A Romanos; W R Whitaker; X M Xie; J J Clare
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

8.  Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy.

Authors:  Franck Kalume; Frank H Yu; Ruth E Westenbroek; Todd Scheuer; William A Catterall
Journal:  J Neurosci       Date:  2007-10-10       Impact factor: 6.167

9.  Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment.

Authors:  Stephen B Long; Xiao Tao; Ernest B Campbell; Roderick MacKinnon
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

10.  Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.

Authors:  Simona Casini; Hanno L Tan; Zahurul A Bhuiyan; Connie R Bezzina; Phil Barnett; Elisabetta Cerbai; Alessandro Mugelli; Arthur A M Wilde; Marieke W Veldkamp
Journal:  Cardiovasc Res       Date:  2007-08-22       Impact factor: 10.787

View more
  43 in total

1.  Extending the clinical spectrum of pain channelopathies.

Authors:  Henry Houlden
Journal:  Brain       Date:  2012-02       Impact factor: 13.501

Review 2.  Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations.

Authors:  Ron Dabby
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

3.  Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons.

Authors:  Jin-Sung Choi; Franck Boralevi; Olivier Brissaud; Jesús Sánchez-Martín; René H M Te Morsche; Sulayman D Dib-Hajj; Joost P H Drenth; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2010-11-16       Impact factor: 42.937

4.  Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.

Authors:  Mirjam Eberhardt; Julika Nakajima; Alexandra B Klinger; Cristian Neacsu; Kathrin Hühne; Andrias O O'Reilly; Andreas M Kist; Anne K Lampe; Kerstin Fischer; Jane Gibson; Carla Nau; Andreas Winterpacht; Angelika Lampert
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

5.  Alternative splicing of Na(V)1.7 exon 5 increases the impact of the painful PEPD mutant channel I1461T.

Authors:  Brian W Jarecki; Patrick L Sheets; Yucheng Xiao; James O Jackson; Theodore R Cummins
Journal:  Channels (Austin)       Date:  2009-07-23       Impact factor: 2.581

Review 6.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 7.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

8.  Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide.

Authors:  Jonathan W Theile; Theodore R Cummins
Journal:  Mol Pharmacol       Date:  2011-07-25       Impact factor: 4.436

9.  Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.

Authors:  Erik T Dustrude; Aubin Moutal; Xiaofang Yang; Yuying Wang; May Khanna; Rajesh Khanna
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

10.  Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.

Authors:  Mark Estacion; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Mol Pain       Date:  2010-06-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.